Quick Search
Filters Clear All
Any Time
- 2026
- 2025
- 2024
- 2023
- 2022
- 2021
- 2020
- 2019
- 2018
- 2017
- 2016
- 2015
- 2014
Product Category
- Antibiotics
- Balanced Salt Solutions
- Cell Dissociation Reagents
- Cell Freezing Media
- Cell Health Assays
- Cell Identification Service
- Cell Lines
- Complete Growth Media
- Cytokines
- Exosome Isolation Kits
- Growth Supplements
- Induced Differentiation Media
- Liquid Basal Media
- Other Reagents
- Powder Basal Media
- Primary Cell Isolation and Culture Kit
- Primary Cells
- Removal Media
- Removal Reagents
- Serum
- Serum-Free Media
Country
- Angola
- Argentina
- Australia
- Austria
- Bangladesh
- Barbados
- Belarus
- Belgium
- Brazil
- Bulgaria
- Burkina Faso
- Burundi
- Cambodia
- Cameroon
- Canada
- Chile
- China
- Chinese Taiwan
- Congo
- Croatia
- Cyprus
- Czech
- Czechia
- Denmark
- Egypt
- Estonia
- Ethiopia
- Finland
- France
- Gabon
- Germany
- Ghana
- Greece
- Guyana
- Hungary
- India
- Indonesia
- Iran
- Iraq
- Ireland
- Israel
- Italy
- Japan
- Kazakhstan
- Kenya
- Korea
- Kuwait
- Kyrgyzstan
- Luxembourg
- Madagascar
- Malaysia
- Mexico
- Mongolia
- Morocco
- Mozambique
- Myanmar
- Nepal
- Netherlands
- New Zealand
- Niger
- Nigeria
- Norway
- Pakistan
- Philippines
- Poland
- Portugal
- Romania
- Russia
- Russian Federation
- Saudi Arabia
- Singapore
- Slovenia
- Somalia
- South Africa
- South Korea
- Spain
- Sri Lanka
- Sudan
- Sweden
- Switzerland
- Syria
- Thailand
- Tunisia
- Turkey
- UAE
- UK
- USA
- Uganda
- Ukraine
- Uruguay
- Uzbekistan
- Vietnam
Publications
Procell has assisted our customers in publishing 32,193 papers in SCI-indexed journals, including leading journals such as Nature Medicine, Nature, Cell, Science, and Signal Transduction and Targeted Therapy.
Filter
-
Novel Hsp90-Targeting PROTACs: Enhanced synergy with cisplatin in combination therapy of cervical cancer (2024-06-06)
Journal: EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2024) IF: 6Products Cited: -
Discovery of novel natural-product-derived mutant isocitrate dehydrogenases 1 inhibitors: Structure-based virtual screening, biological evaluation and structure-activity relationship study (2024-06-17)
Journal: EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2024) IF: 6Products Cited: MEM, with NEAA Medium -
Design, synthesis and antitumor activity of a novel FGFR2-selective degrader to overcome resistance of the FGFR2V564F gatekeeper mutation based on a pan-FGFR inhibitor (2024-06-18)
Journal: EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2024) IF: 6Products Cited: HL-7702 [L-02; LO2] Cells Line, A2780 Cells Line -
Multimechanism biological profiling of tetrahydro-β-carboline analogues as selective HDAC6 inhibitors for the treatment of Alzheimer's disease (2024-06-24)
Journal: EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2024) IF: 6Products Cited: -
Development of novel antivrial agents that induce the degradation of the main protease of human-infecting coronaviruses (2024-06-25)
Journal: EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2024) IF: 6Products Cited: -
Design, synthesis and structure-activity relationships of novel non-ketolides: 9-Oxime clarithromycin featured with seven-to thirteen-atom-length diamine linkers at 3-OH (2024-06-25)
Journal: EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2024) IF: 6Products Cited: Penicillin-Streptomycin Solution, 100 ×, Fetal Bovine Serum -
Carbamoylation at C-8 position of natural 3-arylcoumarin scaffold for the discovery of novel PARP-1 inhibitors with potent anticancer activity (2024-07-31)
Journal: EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2024) IF: 6Products Cited: Fetal Bovine Serum -
Discovery of a novel Xanthone derivative P24 for anti-AD via targeting sTGFBR3 (2024-07-30)
Journal: EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2024) IF: 6Products Cited: -
Glutathione-dependent degradation of SMARCA2/4 for targeted lung cancer therapy with improved selectivity (2024-08-08)
Journal: EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2024) IF: 6Products Cited: HULEC-5a Cells Line -
Design, synthesis and bioactivity evaluation of isobavachin derivatives as hURAT1 inhibitors for hyperuricemia agents (2024-08-11)
Journal: EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2024) IF: 6
